Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SP100 | hg38_v1_chr2_+_230416239_230416266 | 0.71 | 5.6e-06 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 8.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 6.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.5 | 6.4 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.6 | 4.9 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.1 | 4.0 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 3.8 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 3.8 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.4 | 3.5 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.8 | 3.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.5 | 3.2 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 9.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.5 | 6.4 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.0 | 5.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 4.9 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 4.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 4.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 4.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 3.5 | GO:0002102 | podosome(GO:0002102) |
0.2 | 3.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 2.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 7.4 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 5.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 5.2 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.2 | 4.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 4.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.3 | 3.8 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
0.6 | 3.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 3.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 2.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 2.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 5.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 4.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 3.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 3.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 3.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 2.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 2.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 2.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 1.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 14.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 9.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 6.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 4.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 3.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 3.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 3.4 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 2.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 2.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 2.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |